These courses are intended for internal hospital staff.

Activity Description:

This lecture will focus on common types of precancerous and cancerous conditions. We will discuss risk factors and patterns of solar behavior for basal cell carcinoma and squamous cell carcinoma.  Melanoma risk factors, adequate sampling of the melanoma skin lesion, and how to interpret pathology reports for melanoma, will also be discussed.  The participant will be better equipped to recognize skin cancer, to interpret histologic data after biopsy, and to design treatment plans and/or make appropriate referrals for patients with precancers and cancerous skin conditions.   

Target Audience: 

Anesthesiology, Diagnostic Radiology, Gastroenterologist, Internal Medicine, Medical Genetics, Pathology, Primary Care, Physical Medicine & Rehabilitation, Surgery, Urology

Learning Objectives:

  • Identify the risk factors for non-melanoma skin cancer and for melanoma, including patterns of solar exposure and family history.
  • Recognize the clinical signs of common non-melanoma skin cancers, and melanoma.
  • Assess pathology results with regard to non-melanoma skin cancer, and how to treat or refer a patient for appropriate treatment.

Moderator:

Misha Miller, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose. 

Session date: 
07/10/2024 - 12:00pm to 1:00pm MDT
Location: 
The Medical Center of Aurora
1501 S Potomac St
2 South Women's Service Conference Room/Virtual
Aurora, CO 80012
United States
  • 1.00 AMA PRA Category 1 Credit
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance

Please login or register to take this course.
Faculty List: 
Speaker(s)

Misha Miller, MD, FACOG, FAAD, FACMS

has no relevant financial relationships to disclose at this time.